Risk of Malignancy Using the Diagnostic Categories Proposed by the World Health Organization International System for Reporting Pancreaticobiliary Cytopathology
Acta Cytologica · 2022 · 66 (6) · 475-485
DOI: 10.1159/000525276 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Cytologica, online erschienen am 22.06.2022. Verfasst von Pınar Uyar Gocun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Gazi University Faculty of Medicine, Ankara, Turkey. Hauptthemen laut MEDLINE: Pancreatic Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
The World Health Organization (WHO) proposed an updated reporting system for pancreaticobiliary cytology, which moves low-grade malignancies to “positive for malignancy” group and serous cystadenoma to “negative for malignancy” group. The WHO system also created two new categories, namely, pancreatic neoplasia-low grade (PaN-Low) and pancreatic neoplasia-high grade (PaN-High), which includes neoplastic mucinous cysts and stratifies them according to their cytologic atypia. The risk of malignancy (ROM) of the new categories of the WHO system needs to be defined.
Methods
Cytologic slides of all patients, who underwent endoscopic ultrasound (EUS)-guided fine needle aspiration (FNA) biopsy at our institution from January 2010 to December 2021 and had a histopathological or clinical follow-up of at least 6 months, were reviewed and reclassified under the Papanicolaou Society of Cytopathology (PSC) and WHO reporting systems. The absolute ROM was calculated for each category of both reporting systems.
Results
A total of 420 EUS-FNA samples from 410 patients were reviewed and reclassified. The absolute ROM for the proposed WHO system was 35% for “nondiagnostic,” 1.0% for “negative for malignancy,” 69.0% for “atypical,” 11% for “PaN-Low,” 100% for “PaN-High,” 91% for “suspicious for malignancy,” and 100% for “malignant.” Comparatively, the absolute ROM under the PSC reporting system was 34% for “nondiagnostic,” 1.0% for negative (for malignancy), 50.0% for “atypical,” 0.0% for “neoplastic: benign,” 16% for “neoplastic: other,” 88% for “suspicious for malignancy,” and 100% for “positive or malignant.” Conclusion: The proposed WHO international reporting system has advantages regarding risk stratification improvement and case management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Gazi University Faculty of Medicine, Ankara, Turkey.
- Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Gazi University, Ankara, Turkey.
Zitieren
APA
Gocun, P. U., Simsek, B., Ekinci, O., Ekmen, N., Arhan, M., Karakan, T., Ibis, M., & Cindoruk, M. (2022). Risk of Malignancy Using the Diagnostic Categories Proposed by the World Health Organization International System for Reporting Pancreaticobiliary Cytopathology. Acta Cytologica, 66(6), 475-485. https://doi.org/10.1159/000525276
Vancouver
Gocun PU, Simsek B, Ekinci O, Ekmen N, Arhan M, Karakan T, et al. Risk of Malignancy Using the Diagnostic Categories Proposed by the World Health Organization International System for Reporting Pancreaticobiliary Cytopathology. Acta Cytologica. 2022;66(6):475-485. doi:10.1159/000525276
BibTeX
@article{Gocun2022,
author = {Gocun, Pınar Uyar and Simsek, Berkay and Ekinci, Ozgur and Ekmen, Nergis and Arhan, Mehmet and Karakan, Tarkan and Ibis, Mehmet and Cindoruk, Mehmet},
title = {Risk of Malignancy Using the Diagnostic Categories Proposed by the World Health Organization International System for Reporting Pancreaticobiliary Cytopathology},
journal = {Acta Cytologica},
year = {2022},
volume = {66},
number = {6},
pages = {475--485},
doi = {10.1159/000525276}
}
EUVIMED